Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
Clinical trial NCT07204275 · RECRUITING
Trial details
- NCT number
- NCT07204275
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-30
- Primary completion
- 2028-12-29
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.